9:22 AM
Leo Group India
| ||
| Centre may set up Rs 2000 crore venture capital fund to promote R&D in ... Economic Times The Centre may set up a venture capital fund of Rs 2000 crore to promote research and development (R&D) in the pharmaceutical sector. See all stories on this topic » | ||
| Bristol's patent woes persist despite Amylin buy Chicago Tribune (Reuters) - Bristol-Myers Squibb Co stands to become a stronger player in diabetes through its expensive acquisition of Amylin Pharmaceuticals Inc but its earnings and pricy shares remain. See all stories on this topic » | ||
| Government considering Rs 2000 crore venture capital fund for pharma Economic Times "We are considering a proposal of venture capital fund of Rs 2000 crore for drug industry. We are talking with Exim Bank for this." : Anand Sharma. See all stories on this topic » | ||
| The pharmaceutical giant GlaxoSmithKline has agreed to pay more than $35 ... Boston Globe Pharmaceutical giant GlaxoSmithKline has agreed to pay more than $35 million to the Massachusetts Medicaid program as part of a $3 billion settlement with federal and state authorities, the largest health care fraud payment in US history. The massive ... See all stories on this topic » | ||
| NPS Pharmaceuticals to Present at JMP Securities Healthcare Conference National Post NPS Pharmaceuticals to Present at JMP Securities Healthcare Conference. See all stories on this topic » | ||
| ||
| Fitch downgrades Bristol-Myers over debt MarketWatch Earlier this week, Bristol-Myers agreed to buy diabetes-drug maker Amylin Pharmaceuticals Inc. (AMLN) for $5.3 billion, giving Bristol more heft in a fast-growing market. Last week, Bristol's board added $3 billion to its share-repurchase program. See all stories on this topic » | ||
| TEXT-Fitch cuts Bristol-Myers Squibb ratings Reuters Patent Cliff Creates Operational Uncertainty Since 2007, Bristol has been preparing for the inevitable patent lapse of Plavix through operational restructuring actions, debt reduction, cash repatriation, divestiture of non-pharmaceutical businesses ... See all stories on this topic » | ||
| The British Pharmaceutical Crooks are Coming, the British Pharmaceutical ... ThePopTort In all the commentary today about London-based pharmaceutical giant GlaxoSmithKline agreeing to pay a record fine (an honor previously held by Pfizer ) of $3 billion (as well as pleading guilty to some criminal charges), ex-NY guv Eliot Spitzer's ... See all stories on this topic » | ||
| NPS Pharmaceuticals To Present At JMP Securities Healthcare Conference TheStreet.com (press release) NPS Pharmaceuticals, Inc (NASDAQ: NPSP) will present at the Seventh Annual JMP Securities Healthcare Conference in New York on Thursday, July 12, 2012 at 1:30 p. See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment